Alimera Sciences, Inc.
NASDAQ:ALIM
5.54 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Revenue
| 80.754 | 54.129 | 59.029 | 50.82 | 53.943 |
| Cost of Revenue
| 19.584 | 7.977 | 7.03 | 6.941 | 6.626 |
| Gross Profit
| 61.17 | 46.152 | 51.999 | 43.879 | 47.317 |
| Gross Profit Ratio
| 0.757 | 0.853 | 0.881 | 0.863 | 0.877 |
| Reseach & Development Expenses
| 16.626 | 16.228 | 13.778 | 9.668 | 10.992 |
| General & Administrative Expenses
| 18.53 | 12.871 | 12.774 | 11.652 | 13.954 |
| Selling & Marketing Expenses
| 27.946 | 25.987 | 23.069 | 20.384 | 25.004 |
| SG&A
| 46.015 | 38.858 | 35.843 | 32.036 | 38.958 |
| Other Expenses
| 0 | 2.706 | 2.579 | 2.676 | 2.641 |
| Operating Expenses
| 62.641 | 57.792 | 52.2 | 44.38 | 52.591 |
| Operating Income
| -1.932 | -11.64 | -0.201 | -0.501 | -5.274 |
| Operating Income Ratio
| -0.024 | -0.215 | -0.003 | -0.01 | -0.098 |
| Total Other Income Expenses Net
| -18.115 | -6.439 | -3.733 | -4.906 | -4.953 |
| Income Before Tax
| -20.047 | -18.079 | -3.934 | -5.407 | -10.227 |
| Income Before Tax Ratio
| -0.248 | -0.334 | -0.067 | -0.106 | -0.19 |
| Income Tax Expense
| 0.085 | 0.028 | 0.438 | -0.068 | 0.216 |
| Net Income
| -20.132 | -18.107 | -4.372 | -5.339 | -10.443 |
| Net Income Ratio
| -0.249 | -0.335 | -0.074 | -0.105 | -0.194 |
| EPS
| -0.79 | -2.59 | -0.66 | -1.04 | -2.19 |
| EPS Diluted
| -0.79 | -2.59 | -0.66 | -1.04 | -2.19 |
| EBITDA
| -1.115 | -8.934 | 2.378 | 2.175 | -2.633 |
| EBITDA Ratio
| -0.014 | -0.165 | 0.04 | 0.043 | -0.049 |